About Index Trending news
Lists
Pricing
FibroGen

FibroGen

FibroGen

FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biologyto discover, develop, and commercialize novel therapeutics.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$62,000,000
Venture capital
$20,000,000
Employees

Team size

200+
Locations
Xconomy

FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits

Health Science
$62,000,000 Post-IPO equity
biospace

FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC

Health Science